ask="2.70"
ask_size="600"
average_daily_volume="1054270"
bid="2.25"
bid_size="2200"
book_value="0.34"
change="-0.02"
change_from_200_day_moving_average="0.82"
change_from_50_day_moving_average="0.50"
change_from_52_week_high="-1.53"
change_From_52_week_low="1.45"
change_in_percent="-0.78%"
close="2.56"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.49"
ebitda="-12.32M"
eps_estimate_current_year="-1.23"
eps_estimate_next_quarter="-0.34"
eps_estimate_next_year="0.95"
ex_dividend_date="N/A"
float_shares="4441000"
high="2.65"
high_52_weeks="4.09"
last_trade_date="3/9/2017"
last_trade_price="2.56"
last_trade_size="1501"
last_trade_time="4:00pm"
low="2.43"
low_52_weeks="1.11"
market_capitalization="24.54M"
moving_average_200_day="1.74"
moving_average_50_day="2.06"
name="Eyegate Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="8.00"
open="2.45"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+46.90%"
percent_change_from_50_day_moving_average="+24.27%"
percent_change_from_52_week_high="-37.41%"
percent_change_from_52_week_low="+130.63%"
previous_close="2.58"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="2.69"
price_per_book="7.61"
price_per_sales="48.59"
revenue="508889.00"
shares_outstanding="9585000"
short_ratio="1.02"
stock_exchange="NCM"
symbol="EYEG"
volume="219327"
weeks_range_52="1.11 - 4.09"
